|
South Africa[南非药品]
|
| VIREAD® TABLETS |
| VIREAD®TABLETS
SCHEDULINGSTATUS:
S4
PROPRIETARYNAME
(anddosageform):
VIREAD®TABLETS
COMPOSITION:
Eachtabletcontains300mgoftenofovirdisoproxilfumarate,whichisequivalentto245mg.. |
| 录入者：admin 发表于：2014-06-12
查阅全文... |
| DONNATAL ELIXIR |
| DONNATALELIXIR
SCHEDULINGSTATUS:
S5
PROPRIETARYNAME
(anddosageform):
DONNATALELIXIR
COMPOSITION:
Each5mLDonnatalElixircontains:
Phenobarbital
.. |
| 录入者：admin 发表于：2014-06-08
查阅全文... |
| MYSOLINE® Tablets |
| MYSOLINE®Tablets
SCHEDULINGSTATUS:
S3
PROPRIETARYNAME
(anddosageform):
MYSOLINE®Tablets
COMPOSITION:
EachMYSOLINEtabletcontains250mgprimidone.
PHARMACOLOGICALCLASSIFICATIO.. |
| 录入者：admin 发表于：2014-05-28
查阅全文... |
| ALKERAN* 2mg Tablets |
| ALKERAN*2mgTablets
SCHEDULINGSTATUS:
S4
PROPRIETARYNAME
(anddosageform)
ALKERAN*2mgTablets
COMPOSITION
EachALKERANtabletcontains2mgmelphalan.
PHARMACOLOGICALCLASSIFICATION:
A26Cy.. |
| 录入者：admin 发表于：2014-05-02
查阅全文... |
| AZACTAM 1g INJECTION |
| AZACTAM1gINJECTION
SCHEDULINGSTATUS:
S4
PROPRIETARYNAME
(anddosageform):
AZACTAM1gINJECTION
COMPOSITION
Aztreonamischemicallydesignatedas(Z)-2-[[[(2-amino-4-thiazolyl)-[[(2S,3S)-2-me.. |
| 录入者：admin 发表于：2014-04-23
查阅全文... |
| ALKERAN* 2mg Tablets |
| ALKERAN*2mgTablets
SCHEDULINGSTATUS:
S4
PROPRIETARYNAME
(anddosageform)
ALKERAN*2mgTablets
COMPOSITION
EachALKERANtabletcontains2mgmelphalan.
PHARMACOLOGICALCLASSIFICATION:
A26Cy.. |
| 录入者：admin 发表于：2014-04-07
查阅全文... |
| CIPROBAY® HC OTIC DROPS |
| CIPROBAY®HCOTICDROPS
SCHEDULINGSTATUS:
S4
PROPRIETARYNAME
(anddosageform):
CIPROBAY®HCOTICDROPS
Eardrops
COMPOSITION
EachmLcontainsciprofloxacinhydrochlorideequivalentto2mgc.. |
| 录入者：admin 发表于：2014-03-01
查阅全文... |
| MABCAMPATH |
| MABCAMPATH
SCHEDULINGSTATUS:
S4
PROPRIETARYNAME
(anddosageform):
MABCAMPATH
Solutionforintravenousinfusion
COMPOSITION
Eachampoulecontains30mgalemtuzumab(10mg/mLconcentratesolutio.. |
| 录入者：admin 发表于：2014-02-16
查阅全文... |
| MABCAMPATH |
| MABCAMPATH
SCHEDULINGSTATUS:
S4
PROPRIETARYNAME
(anddosageform):
MABCAMPATH
Solutionforintravenousinfusion
COMPOSITION
Eachampoulecontains30mgalemtuzumab(10mg/mLconcentratesolutio.. |
| 录入者：admin 发表于：2014-02-16
查阅全文... |
| ASPEN ESCITALOPRAM |
| ASPENESCITALOPRAM
SCHEDULINGSTATUS:
S5
PROPRIETARYNAME
(anddosageform):
ASPENESCITALOPRAM
ASPENESCITALOPRAM5mg(film-coatedtablet)
ASPENESCITALOPRAM10mg(filmcoatedtablet)
ASPENESCITA.. |
| 录入者：admin 发表于：2013-12-25
查阅全文... |
| FLUDARA |
| FLUDARA
SCHEDULINGSTATUS:
S4
PROPRIETARYNAME
(anddosageform):
FLUDARA
Sterilelyophilisedsolidcakeforsolution
COMPOSITION
Eachvialcontains50mgfludarabinephosphateasalyophilisedsolidc.. |
| 录入者：admin 发表于：2013-12-05
查阅全文... |
| CREON CAPSULES |
| CREONCAPSULES
SCHEDULINGSTATUS:
S1
PROPRIETARYNAME
(anddosageform):
CREONCAPSULES
COMPOSITION
Percapsule:pancreatin300mg.
Theenzymeactivitiespercapsuleare:
Amylas.. |
| 录入者：admin 发表于：2013-11-30
查阅全文... |
| CREON 25000 capsules |
| CREON25000capsules
SCHEDULINGSTATUS:
S1
PROPRIETARYNAME
(anddosageform):
CREON25000capsules
COMPOSITION
Percapsule:pancreatin300mg.
Theenzymeactivitiespercapsuleare:
.. |
| 录入者：admin 发表于：2013-11-30
查阅全文... |
| HYDREA CAPSULES |
| HYDREACAPSULES
SCHEDULINGSTATUS:
S4
PROPRIETARYNAME
(anddosageform):
HYDREACAPSULES
COMPOSITION
Eachcapsulecontains500mghydroxyurea.
PHARMACOLOGICALCLASSIFICATION
CategoryA26Cyto.. |
| 录入者：admin 发表于：2013-11-15
查阅全文... |
| MABCAMPATH |
| MABCAMPATH
SCHEDULINGSTATUS:
S4
PROPRIETARYNAME
(anddosageform):
MABCAMPATH
Solutionforintravenousinfusion
COMPOSITION
Eachampoulecontains30mgalemtuzumab(10mg/mLconcentratesolutio.. |
| 录入者：admin 发表于：2013-11-03
查阅全文... |
| MABCAMPATH |
| MABCAMPATH
SCHEDULINGSTATUS:
S4
PROPRIETARYNAME
(anddosageform):
MABCAMPATH
Solutionforintravenousinfusion
COMPOSITION
Eachampoulecontains30mgalemtuzumab(10mg/mLconcentratesolutio.. |
| 录入者：admin 发表于：2013-10-30
查阅全文... |
| ALKERAN* 2mg Tablets |
| ALKERAN*2mgTablets
SCHEDULINGSTATUS:
S4
PROPRIETARYNAME
(anddosageform)
ALKERAN*2mgTablets
COMPOSITION
EachALKERANtabletcontains2mgmelphalan.
PHARMACOLOGICALCLASSIFICATION:
A26Cy.. |
| 录入者：admin 发表于：2013-10-27
查阅全文... |
|
